metastatic insulinoma. At laparotomy the primary tumour in the tail of the pancreas was removed, but at least two hepatic metastases were left behind. The propensity to develop fasting hypoglycemia was uninfluenced, and three hourly feeds were necessary to prevent the occurrence of neuroglycopenic episodes with loss of consciousness; blood glucose levels after 3-4 hour fast being in the region of 20-30 mg.jlOO ml. Prednisone in large doses was tried without effect. Therapy with diazoxide-600 mg.jday, reducing to 400 mg.jday after one week-was instituted in November, 1964 with immediate benefit. Normoglycamia was restored; overnight fasting was well tolerated and blood glucose level after a 12-14 hour fast were consistently between 70-90 mg.jlOO ml. Apart from nausea for two days whilst on the larger (600 mg.jday) dose, there have been no untoward side effects from this drug.
The patient returned to work in January, 1965 and has been subjectively in perfect health since treatment began. His diet, appetite and weight are now (August, 1965) the same as before the onset of the illness.
The results of investigations designed to determine the mode of action of diazoxide will be published in greater detail elsewhere. Compared with before treatment, volume of distribution of injected glucose increased almost 50 %. Fasting plasma insulin, which was initially high, began gradually to fall after four days on diazoxide, eventually reaching normal levels at which it has remained. Peripheral glucose utilization, markedly impaired at first, improved with time, and was possibly the major factor contributing to the rise in the fasting blood glucose concentration, though the fall in plasma insulin, which occurred later, undoubtedly served to maintain the therapeutic response. Fasting plasma NEFA did not rise significantly except during a short period of excessive hyperglycemia which occurred with the larger dose of diazoxide. These results differ from those reported by Ernesti et al, (1965) in a similar case, possibly due to their use-in addition to diazoxide-of other hyperglycemic agents, including diuretic benzothiadiazines which enhance the blood glucose raising properties of diazoxide (Wolff and Parmley, 1963), but not necessarily in the same way.
The clinical improvement observed in this patient in response to diazoxide is unique in our experience of malignant insulinomata, but is similar to that observed by one of us (E.S.) in a second patient with malignant insulinoma treated with diazoxide. Preliminary studies in a further patient with hypoglycemia due to glycogen storage disease, and encouraging reports of the usefulness of diazoxide in the treatment of other varieties of hypoglycemia which are unamenable to specific curative therapy (Drash and Wolff, 1964) , suggest that further trials of the drug, either alone or in combination with diuretic benzothiadiazines, are amply justified. As part of a study of plasma fibrinogen and factor VIII in health and disease, we have estimated the amino-acid components of human plasma fibrinogen. Oxalated plasma was used and the fibrinogen converted into fibrin by the addition of calcium. The fibrin clot was filtered off, well washed with saline and hydrolysed for 12-14 hours, at 115°C., in 6N HC!. in sealed tube, filled with nitrogen. The amino-acids were estimated, using the Auto-Technicon Aminoacid analyser, with nor-leucine as the added reference standard.
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The range, mean and standard deviation of 17 amino-acids in the fibrinogen of 10 normal subjects were determined. Five amino-acidsaspartic acid, glutamic acid, glycine, serine and lysine-accounted for more than 50 % of the total amino-acids, six other amino-acids, present in smaller amounts-threonine, proline, alanine, valine, leucine and arginine-accounted for 30 % and six more were present in small or trace amounts. Considerable variations in several amino-acids were demonstrated and the range was wide (Table I) . The use of different columns of resin for analysing the same plasma fibrinogen resulted in some variation in the amounts of amin-acid estimated-in the more prevalent, this amounted up to 8 %of the amino-acid. This was regarded as experimental error, inherent in this method. Amino-acid composition of Fibrinogen (Percentage of total amino-acids).
Serial determination of plasma of the same control subject showed only those differences which were within the experimental error.
The amino-acids of fibrinogen, taken from patients, suffering from conditions in which alterations in the amount of fibrinogen occur, were also estimated.
Following an operation for a chronic orthopedic disease, the plasma fibrinogen rose from 394 to 943 mg.jl00 ml. plasma in four days but the differences in the amino-acids found on serial determination were all within the experimental error, suggesting that fibrinogen varied only in quantity and not in its amino-acid make-up.
Another illness, connected with a raised fibrinogen, is coronary thrombosis, and serial determinations were made at weekly intervals during recovery in several cases. In one case, in which the plasma fibrinogen rose to 510 mg.j 100 ml. plasma, the first specimen, collected 2 days after the thrombosis, showed an amino-acid pattern that was just within the normal range but during the recovery there was a fall in the aspartic acid, a rise followed by a fall in the serine and a rise in the lysine component. Two other cases, however showed no such changes but did show a fall in the glutamic acid levels. No clear pattern of change was apparent.
Similar changes have been demonstrated in infection and arthritis. It is concluded that the changes in the levels of plasma fibrinogen, seen in these diseases, is not reflected in changes of the amino-acid make-up.
Eight cystinurics from six families have been examined together with relatives. Urine samples are applied directly to the column, except where protein is present in detectable amounts. In these cases deproteinisation is carried out, either by passage through Amberlite IR-120 (H) and The free amino-acid content of urine samples elution of the amino-acids with 5M ammonia, from several cystinurics and their relatives have or by precipitation with 5 volumes of 5 % tribeen studied using the Technicon Amino-acid choloracetic acid and removal of the excess acid Analyser recently installed in this department. with ether. The amino-acid content of the urines A case of cystinosis has also been studied.
is expressed in mg. amino-acid per g. creatinine.
The urines fall into three groups with respect to amino-acid content: those with normal amounts, having a cystine content of below 50 mg.jg. creatinine, lysine of below 80 mg.jg. creatinine, and arginine and ornithine of below 15 mg.jg. creatinine; those with moderate amounts, typical of heterozygotes of the "incompletely recessive"
